RNS System

1 articles
The Motley FoolThe Motley Fool··Eric Volkman

NeuroPace Beats Earnings Expectations, But 2026 Outlook Cools Rally

NeuroPace shares rose nearly 1% after Q4 earnings beat expectations with $26.6M revenue (24% YoY growth) and narrowed losses, though 2026 guidance disappointed investors.
NPCEnet lossrevenue growth